Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use THIOTEPA FOR INJECTION safely and effectively. See full prescribing information for THIOTEPA FOR INJECTION. THIOTEPA for injection, for intravenous, intracavitary, or intravesical use. Initial U.S. Approval: 1959
Medication labelWhy this: Advisory · dailymed-prescription
Thiotepa for injection is indicated for treatment of adenocarcinoma of the breast or ovary. Thiotepa for injection is indicated for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities. Thiotepa for injection is indicated for treatment of superficial papillary carcinoma of the urinary bladder. Pediatric use information is approved for Adienne SA' s TEPADINA (thiotepa) for Injection. However, due to Adienne SA's marketing exclusivity rights, the drug product is not labeled with that information.
- generic_name
- thiotepa
- product_names
- Thiotepa
- ndc
- 65219-029, 65219-029-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en